Evidence map›Paper›PMID 27626498›Full record

ArticleOncotarget2016

DRG1 is a potential oncogene in lung adenocarcinoma and promotes tumor progression via spindle checkpoint signaling regulation.

Li Lu, Yanrong Lv, Ji Dong, Shaohua Hu, Ruiyun Peng

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Substrate selectivity and inhibition of the human lysyl hydroxylase JMJD7.Protein science : a publication of the Protein Society · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Developmentally regulated GTPases: structure, function and roles in disease.Cellular and molecular life sciences : CMLS · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Li LuDepartment of Experimental Pathology, Beijing Institute of Radiation Medicine, Beijing, China.
Yanrong LvDepartment of Breast Surgery, QiLu Hospital of Shandong University, Jinan, Shandong, China.
Ji DongDepartment of Experimental Pathology, Beijing Institute of Radiation Medicine, Beijing, China.
Shaohua HuDepartment of Experimental Pathology, Beijing Institute of Radiation Medicine, Beijing, China.
Ruiyun PengDepartment of Experimental Pathology, Beijing Institute of Radiation Medicine, Beijing, China.
Beijing Radiation Center · CNQilu Hospital of Shandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developmentally regulated GTP binding protein 1 (DRG1), a member of the DRG family, plays important roles in regulating cell growth. However, the molecular basis of DRG1 in cell proliferation regulation and the relationship between DRG1 and tumor progression remain poorly understood. Here, we demonstrate that DRG1 is elevated in lung adenocarcinomas while weakly expressed in adjacent lung tissues. DRG1 knockdown causes growth inhibition of tumor cells by significantly increasing the proportion of cells in M phase. Overexpression of DRG1 leads to chromosome missegregation which is an important index for tumorigenesis. Interestingly, ectopic of DRG1 reduces taxol induced apoptosis of lung adenocarcinoma cells. Mechanistic analyses confirm that DRG1 localizes at mitotic spindles in dividing cells and binds to spindle checkpoint signaling proteins in vivo. These studies highlight the expanding role of DRG1 in tumorigenesis and reveal a mechanism of DRG1 in taxol resistance.

Indexed as

M Phase Cell Cycle CheckpointsSignal TransductionAdenocarcinomaAdenocarcinoma of LungAntineoplastic AgentsApoptosisCell CycleChromosome SegregationDisease ProgressionGene Expression Regulation, NeoplasticGTP-Binding ProteinsHumansLung NeoplasmsMitosisOncogenesSpindle ApparatusAntineoplastic Agentsdevelopmentally regulated GTP-binding proteinGTP-Binding Proteinschemoresistancedevelopmentally regulated GTP-binding protein 1lung adenocarcinomaspindle checkpoint

Identifiers

PMID27626498
PMCPMC5341944
OpenAlexW2518889752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.